Arrhythmogenic effects of illicit drugs in athletes

Francesco Furlanello1, Stefano Bentivegna, Riccardo Cappato

  • 1Center of Clinical Arrhythmia and Electrophysiology, Istituto Policlinico San Donato, University of Milan, San Donato, Milanese, MI, Italy. furlanello@interfree.it

Insights

Illicit drug abuse in athletes can cause serious cardiac arrhythmias, even in those without prior heart conditions. Cardiologists must consider drug use when managing arrhythmic athletes, as it can trigger or worsen heart rhythm disorders.

Area of Science:

  • Sports Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Cardiac arrhythmias are a primary reason for disqualification from sports.
  • Illicit drug use is prevalent among athletes and poses significant health risks.
  • Various substances banned by the World Anti-Doping Agency can affect cardiac function.

Purpose of the Study:

  • To highlight the arrhythmogenic potential of illicit drugs in athletes.
  • To emphasize the importance of considering drug abuse in the diagnosis of cardiac arrhythmias.
  • To inform cardiologists about the link between illicit substances and heart rhythm disorders.

Main Methods:

  • Review of banned substances by the World Anti-Doping Agency.
  • Analysis of the arrhythmogenic mechanisms of illicit drugs.
  • Clinical considerations for cardiologists managing arrhythmic athletes.

Main Results:

  • Nearly all illicit drugs can induce various cardiac arrhythmias (supraventricular and ventricular).
  • Arrhythmias can occur acutely or chronically, even in individuals with no known heart disease.
  • Illicit drugs can exacerbate underlying arrhythmogenic heart conditions, increasing sudden cardiac death risk.

Conclusions:

  • Cardiologists must suspect illicit drug use in athletes presenting with arrhythmias, especially when cardiac disease is absent.
  • Awareness of drug-induced arrhythmias is crucial for accurate diagnosis and management in sports cardiology.
  • Illicit substances represent a significant and often overlooked cause of cardiac arrhythmias in the athletic population.

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...